Posted by Michael Wonder on 15 Apr 2020
Vaccine development becomes reality TV. Can it make viewers rethink pharma?
14 April 2020 - The pharmaceutical industry’s response to the novel coronavirus may not rescue its ailing reputation. But it will, apparently, be televised — and the footage could nudge the public’s perception of how the drug business works.
That, at least, is the thinking behind a 30 minute weekly show from the multinational drug company Johnson & Johnson being launched Tuesday.
The eight episode series, which will be broadcast live online, will focus on the company’s efforts to find a vaccine for the virus that causes COVID-19. Johnson & Johnson has hired journalist Lisa Ling, of CNN’s “This Is Life,” to host the program.
